146 related articles for article (PubMed ID: 38431305)
1. The crucial role of age and site in incidence and prognosis of female neuroendocrine neoplasms in the United States: a population-based study from 2000 to 2018.
Xiao G; Xu Z; Zhang Y; Dai S; Ouyang G; Huang Y; Liu Y; Cao D; Luo F
Aging (Albany NY); 2024 Mar; 16(5):4204-4223. PubMed ID: 38431305
[TBL] [Abstract][Full Text] [Related]
2. Incidence and survival trends for gastric neuroendocrine neoplasms: An analysis of 3523 patients in the SEER database.
Cao LL; Lu J; Lin JX; Zheng CH; Li P; Xie JW; Wang JB; Chen QY; Lin M; Tu RH; Huang CM
Eur J Surg Oncol; 2018 Oct; 44(10):1628-1633. PubMed ID: 29983275
[TBL] [Abstract][Full Text] [Related]
3. Epidemiologic Trends of and Factors Associated With Overall Survival for Patients With Gastroenteropancreatic Neuroendocrine Tumors in the United States.
Xu Z; Wang L; Dai S; Chen M; Li F; Sun J; Luo F
JAMA Netw Open; 2021 Sep; 4(9):e2124750. PubMed ID: 34554237
[TBL] [Abstract][Full Text] [Related]
4. Trends of incidence and prognosis of gastric neuroendocrine neoplasms: a study based on SEER and our multicenter research.
Hu P; Bai J; Liu M; Xue J; Chen T; Li R; Kuai X; Zhao H; Li X; Tian Y; Sun W; Xiong Y; Tang Q
Gastric Cancer; 2020 Jul; 23(4):591-599. PubMed ID: 32026156
[TBL] [Abstract][Full Text] [Related]
5. Development and validation of a nomogram for predicting the overall survival of patients with gastroenteropancreatic neuroendocrine neoplasms.
Xie S; Li L; Wang X; Li L
Medicine (Baltimore); 2021 Jan; 100(2):e24223. PubMed ID: 33466202
[TBL] [Abstract][Full Text] [Related]
6. Epidemiological trends and novel prognostic evaluation approaches of patients with stage II-IV colorectal neuroendocrine neoplasms: A population-based study with external validation.
Zhao F; Huang L; Wang Z; Wei F; Xiao T; Liu Q
Front Endocrinol (Lausanne); 2023; 14():1061187. PubMed ID: 36817582
[TBL] [Abstract][Full Text] [Related]
7. Development and validation of prognostic nomograms for patients with colon neuroendocrine neoplasms.
Xu R; Zhou B; Hu P; Xue B; Gu D; Li X; Tang Q
World J Surg Oncol; 2021 Aug; 19(1):233. PubMed ID: 34364382
[TBL] [Abstract][Full Text] [Related]
8. Development and Validation of Prognostic Nomograms for Patients with Duodenal Neuroendocrine Neoplasms.
Sun S; Wang W; He C
Med Sci Monit; 2020 Jun; 26():e922613. PubMed ID: 32564052
[TBL] [Abstract][Full Text] [Related]
9. Risk and prognostic nomograms for colorectal neuroendocrine neoplasm with liver metastasis: a population-based study.
Ding X; Tian S; Hu J; Wang G; Yu X; Fu D; Yuan Y; Wang L; Wang Z
Int J Colorectal Dis; 2021 Sep; 36(9):1915-1927. PubMed ID: 34061225
[TBL] [Abstract][Full Text] [Related]
10. Comparative prognosis and risk assessment in gallbladder neuroendocrine neoplasms versus adenocarcinomas.
Zhao ZH; Huang Y; Jiang C; Lv GY; Wang M
Front Endocrinol (Lausanne); 2024; 15():1326112. PubMed ID: 38390209
[TBL] [Abstract][Full Text] [Related]
11. A Nomogram to Predict Individual Survival of Patients with Liver-Limited Metastases from Gastroenteropancreatic Neuroendocrine Neoplasms: A US Population-Based Cohort Analysis and Chinese Multicenter Cohort Validation Study.
Xu G; Xiao Y; Hu H; Jin B; Wu X; Wan X; Zheng Y; Xu H; Lu X; Sang X; Ge P; Mao Y; Cai J; Zhao H; Du S
Neuroendocrinology; 2022; 112(3):263-275. PubMed ID: 33902058
[TBL] [Abstract][Full Text] [Related]
12. A prognostic nomogram based on log odds of positive lymph nodes to predict the overall survival in biliary neuroendocrine neoplasms (NENs) patients after surgery.
Jiang S; Yang F; Zhang L; Sang X; Lu X; Zheng Y; Xu Y
J Endocrinol Invest; 2022 Dec; 45(12):2341-2351. PubMed ID: 35908009
[TBL] [Abstract][Full Text] [Related]
13. Pattern and risk factors for distant metastases in gastrointestinal neuroendocrine neoplasms: a population-based study.
Cai W; Tan Y; Ge W; Ding K; Hu H
Cancer Med; 2018 Jun; 7(6):2699-2709. PubMed ID: 29733523
[TBL] [Abstract][Full Text] [Related]
14. Incidence and survival of neuroendocrine neoplasms in China with comparison to the United States.
Zheng R; Zhao H; An L; Zhang S; Chen R; Wang S; Sun K; Zeng H; Wei W; He J
Chin Med J (Engl); 2023 May; 136(10):1216-1224. PubMed ID: 37022941
[TBL] [Abstract][Full Text] [Related]
15. A Real-World, Population-Based Study for the Incidence and Outcomes of Neuroendocrine Neoplasms of Unknown Primary.
Abdel-Rahman O
Neuroendocrinology; 2021; 111(9):876-882. PubMed ID: 32980845
[TBL] [Abstract][Full Text] [Related]
16. Clinicopathologic characteristics and prognosis of gastroenteropancreatic neuroendocrine neoplasms: a multicenter study in South China.
Fang C; Wang W; Zhang Y; Feng X; Sun J; Zeng Y; Chen Y; Li Y; Chen M; Zhou Z; Chen J
Chin J Cancer; 2017 Jun; 36(1):51. PubMed ID: 28637502
[TBL] [Abstract][Full Text] [Related]
17. Epidemiological features of primary breast lymphoma patients and development of a nomogram to predict survival.
Peng F; Li J; Mu S; Cai L; Fan F; Qin Y; Ai L; Hu Y
Breast; 2021 Jun; 57():49-61. PubMed ID: 33774459
[TBL] [Abstract][Full Text] [Related]
18. A prognostic nomogram in patients with distant metastasis of pancreatic neuroendocrine tumors: a population-based study.
Cai JS; Chen HY; Lu YF; Yu RS
Future Oncol; 2020 Jan; 16(2):4369-4379. PubMed ID: 31802701
[No Abstract] [Full Text] [Related]
19. Epidemiologic trends and survival of early-onset gastroenteropancreatic neuroendocrine neoplasms.
Yao H; Hu G; Jiang C; Fan M; Yuan L; Shi H; Lin R
Front Endocrinol (Lausanne); 2023; 14():1241724. PubMed ID: 37701903
[TBL] [Abstract][Full Text] [Related]
20. Nomograms for Predicting Survival Outcomes in Patients with Neuroendocrine Neoplasms of the Gallbladder Undergoing Primary Tumor Resection: A Population-Based Study.
Zhang YR; Hu GC; Fan MK; Yao HL; Jiang C; Shi HY; Lin R
Curr Oncol; 2023 Feb; 30(3):2889-2899. PubMed ID: 36975434
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
